Filing Details

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

Culp, Inc.

(Name of Issuer)

Common Stock, par value $0.05 per share

(Title of Class of Securities)

230215105

(CUSIP Number)

Mill Road Capital III, L.P.

Attn: Thomas E. Lynch

328 Pemberwick Road

Greenwich, CT 06831

203-987-3500

With a copy to:

Peter M. Rosenblum, Esq.

Foley Hoag LLP

155 Seaport Blvd.

Boston, MA 02210

617-832-1000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

December 5, 2023

(Date of Event which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☒

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are sent.

 

 

*	The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 230215105		13D		Page 2 of 8 Pages

 

1.		Names of Reporting Persons     Mill Road Capital III, L.P.
2.		Check the Appropriate Box if a Member of a Group (See Instructions)   (a)  ☐        (b)  ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions)     WC
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     ☐
6.		Citizenship or Place of Organization     Cayman Islands

Number of Shares  Beneficially  Owned by Each Reporting Person With				7.		Sole Voting Power     681,269
				8.		Shared Voting Power
				9.		Sole Dispositive Power     681,269
				10.		Shared Dispositive Power

11.		Aggregate Amount Beneficially Owned by Each Reporting Person     681,269
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     ☐
13.		Percent of Class Represented by Amount in Row (11)     5.5%
14.		Type of Reporting Person (See Instructions)     PN

CUSIP No. 230215105		13D		Page 3 of 8 Pages

 

1.		Names of Reporting Persons     Mill Road Capital III GP LLC
2.		Check the Appropriate Box if a Member of a Group (See Instructions)   (a)  ☐        (b)  ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions)     AF
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     ☐
6.		Citizenship or Place of Organization     Cayman Islands

Number of Shares  Beneficially  Owned by Each Reporting Person With				7.		Sole Voting Power     681,269
				8.		Shared Voting Power
				9.		Sole Dispositive Power     681,269
				10.		Shared Dispositive Power

11.		Aggregate Amount Beneficially Owned by Each Reporting Person     681,269
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     ☐
13.		Percent of Class Represented by Amount in Row (11)     5.5%
14.		Type of Reporting Person (See Instructions)     OO

CUSIP No. 230215105		13D		Page 4 of 8 Pages

 

1.		Names of Reporting Persons     Thomas E. Lynch
2.		Check the Appropriate Box if a Member of a Group (See Instructions)   (a)  ☐        (b)  ☐
3.		SEC Use Only
4.		Source of Funds (See Instructions)     AF
5.		Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     ☐
6.		Citizenship or Place of Organization     USA

Number of Shares  Beneficially  Owned by Each Reporting Person With				7.		Sole Voting Power
				8.		Shared Voting Power     681,269
				9.		Sole Dispositive Power
				10.		Shared Dispositive Power     681,269

11.		Aggregate Amount Beneficially Owned by Each Reporting Person     681,269
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     ☐
13.		Percent of Class Represented by Amount in Row (11)     5.5%
14.		Type of Reporting Person (See Instructions)     HC; IN

CUSIP No. 230215105				Page 5 of 8 Pages

 

This Amendment No. 1 to the joint statement on Schedule 13D with respect to the common stock, par value $0.05 (the Common Stock), of Culp, Inc., a North Carolina corporation (the Issuer), filed by Thomas E. Lynch, Mill Road Capital III GP LLC, a Cayman Islands limited liability company, and Mill Road Capital III, L.P., a Cayman Islands exempted limited partnership (collectively, the Reporting Persons) on December 13, 2022 (such joint statement, as amended herein, the Schedule 13D), amends the Schedule 13D as follows:

 

1.	Paragraphs (b) and (c) of Item 2 of the Schedule 13D shall hereby be amended and restated in full as follows:

(b)The business address of Mr. Lynch, Mr. Jacobs, Mr. Petito, and Mr. Yanagi, and the address of the principal business and the principal office of the Fund and the GP, is 334 Pemberwick Road, Second Floor, Greenwich, CT 06831.

(c)The principal business of the GP is acting as the sole general partner of the Fund. The principal business of the Fund is investing in securities. The present principal occupation or employment of each Manager is as a management committee director of the GP and Mill Road Capital Management LLC, a Delaware limited liability company (the Management Company), which provides advisory and administrative services to the GP and is located at 334 Pemberwick Road, Second Floor, Greenwich, CT 06831.

 

2.	Item 3 of the Schedule 13D shall hereby be amended and restated in full as follows:

 

Item 3.

Source and Amount of Funds or Other Consideration

The Reporting Persons acquired beneficial ownership of an aggregate of 681,269 shares of Common Stock for $6,154,647.83 using working capital from the Fund and the proceeds of margin loans under margin loan facilities maintained in the ordinary course of business by the Fund with a broker on customary terms and conditions. The purchase price of shares acquired pursuant to the assignment of standard American-style, exchange-traded put options (Put Options) is not reduced by the premium received by the Reporting Persons upon sale of the Put Options.

 

3.	Paragraphs (a), (b), and (c) of Item 5 of the Schedule 13D shall hereby be amended and restated in full as follows:

(a, b) The percentages of beneficial ownership reported in this Item 5, and on each Reporting Persons cover page to this Schedule 13D, are based on a total of 12,457,346 shares of Common Stock issued and outstanding as of September 5, 2023, as reported in the Issuers quarterly report on Form 10-Q for the fiscal quarter ended July 30, 2023. All of the share numbers reported below, and on each Reporting Persons cover page to this Schedule 13D, are as of December 7, 2023, unless otherwise indicated. The cover page to this Schedule 13D for each Reporting Person is incorporated by reference in its entirety into this Item 5(a, b).

The Fund directly holds, and thus has sole voting and dispositive power over, 681,269 shares of Common Stock. The GP, as sole general partner of the Fund, also has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund, and Mr. Lynch has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP.

CUSIP No. 230215105				Page 6 of 8 Pages

 

Accordingly, each of the Reporting Persons beneficially owns 681,269 shares of Common Stock, or approximately 5.5% of the outstanding shares of Common Stock, and the Reporting Persons beneficially own, in the aggregate, 681,269 shares of Common Stock, or approximately 5.5% of the outstanding shares of Common Stock.

(c) No Reporting Person, other than the Fund as set forth in the table below and as described in Item 6, effected any transaction in shares of the Common Stock from October 8, 2023 (the date 60 days prior to the filing of this Schedule 13D) to December 7, 2023 (the Reporting Period):

 

Date of Sale		Shares Sold (#)				Sale Price per Share ($)
11/17/2023			14,200			$	5.0000

The above listed transaction was conducted by the assignment of 142 standard American-style, exchange-traded call options resulting in the sale of 14,200 shares of the Issuer. The sale price does not reflect brokerage commissions paid.

 

4.	Item 6 of the Schedule 13D shall hereby be amended and restated in full as follows:

 

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

The table below lists the standard American-style, exchange-traded call options (Call Options) sold by the Fund during the Reporting Period that are outstanding as of December 7, 2023. Each of the below listed transactions was conducted in the ordinary course of business on the open market for cash, and the sale prices do not reflect brokerage commissions paid.

 

Date of Sale of Call Options		Sale Price per Underlying Share of Call Option ($)				Underlying Shares (#) (100s)				Strike Price per Share ($)				Call Option Expiration Date
11/03/2023		$	0.6000				99			$	5.00				12/15/2023
11/07/2023		$	0.6000				50			$	5.00				12/15/2023
11/16/2023		$	0.3506				345			$	5.00				12/15/2023
11/27/2023		$	0.3500				40			$	5.00				01/19/2024
12/05/2023		$	0.6000				89			$	5.00				12/15/2023
12/05/2023		$	0.5798				948			$	5.00				01/19/2024
12/06/2023		$	0.3933				1,052			$	5.00				01/19/2024

Each of these Call Options gives the options counterparty the right (but not the obligation) to purchase from the Fund, on or before the options expiration date, the number of shares of Common Stock underlying the option, at a purchase price per share equal to the options strike price per share. If a Call Option is exercised on or before its expiration date, the Fund must deliver the shares of Common Stock underlying the option in exchange for the options aggregate exercise price.

CUSIP No. 230215105				Page 7 of 8 Pages

 

Except as otherwise described in this Schedule 13D, including the Exhibits attached hereto, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons, or between the Reporting Persons and any third party, with respect to any securities of the Issuer, including, but not limited to, those involving the transfer or voting of securities, finders fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.

[signature pages follow]

CUSIP No. 230215105				Page 8 of 8 Pages

 

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.